The precision of elite sport.
Applied to clinical decision making.
The precision
of elite sport.
Applied to healthcare.
Elite sports measure movement because objective data improves decisions. Healthcare still relies heavily on observation for conditions where movement determines recovery. Moviq Health brings laboratory-grade biomechanics into routine clinical care, transforming human movement into objective evidence clinicians can use to guide treatment, monitor progress, and document outcomes.
The standard of elite sport.
Now the standard for healthcare.
Elite athletes are measured because the smallest changes in movement can influence performance, recovery, and injury risk. Objective biomechanics provides the evidence needed to make confident, high-stakes decisions.
Movement influences decisions about fall risk, rehabilitation, surgical recovery, neurological disease, and functional independence. Every patient deserves objective movement measurement that makes change visible, measurable, and clinically meaningful.
The questions clinicians ask.
The data that answers them.
Objective evidence determines whether recovery is progressing normally or whether meaningful deficits persist.
Comparing objective measurements to healthy population reference standards reveals whether function is normal, impaired, or meaningfully below expectation.
Most falls are preceded by measurable changes in balance. Observation alone often misses them.
Symptoms fluctuate. Objective measurements reveal whether treatment is producing meaningful functional change.
Symptoms may improve before function does. Objective testing identifies residual deficits that increase reinjury risk.
Observation creates questions.
Measurement produces answers.
Not more data.
More clarity.
Every report begins with a clinical summary written by a Doctor of Physical Therapy that translates objective measurements into actionable findings.
- Clinical interpretation
- Standardized Measurement
- Population reference values
- Longitudinal comparison
- Quantified impairment
- Decision support
Clinical biomechanics testing demonstrated gait function within normative limits (1.10 m/s). Force analysis revealed reduced peak force (10.2 N/kg vs. ≥11.5 N/kg), diminished rate of force development (26 vs. ≥30 N/s/kg), and persistent loading asymmetry (16% vs. ≤10%). Balance assessment identified elevated postural sway (46 cm vs. ≤30 cm). Collectively, these findings are consistent with elevated fall risk despite preserved ambulatory performance.
| Metric | Domain | Measured | Ref. Range | Status |
|---|---|---|---|---|
| Gait Speed (m/s) | Gait | 1.10 | ≥ 1.00 | Within |
| Cadence (spm) | Gait | 108 | ≥ 100 | Within |
| L Stride Length (cm) | Gait | 124 | ≥ 120 | Within |
| R Stride Length (cm) | Gait | 128 | ≥ 120 | Within |
| Peak Force (N/kg) | Force | 10.2 | ≥ 11.5 | Outside |
| Peak RFD (N/s/kg) | Force | 26 | ≥ 30 | Outside |
| Force Symmetry Index (%) | Force | 16 % | ≤ 10 % | Outside |
| Postural Sway (cm) | Balance | 46 | ≤ 30 | Outside |
| Limits of Stability (cm²) | Balance | 460 | ≥ 370 | Within |
The next standard of care.
The future of healthcare is informed patients.
Become a Clinical Partner
Objective movement measurement gives your patients measurable progress, standardized reporting, and evidence that supports every important movement-based decision.
The standard trusted by elite athletes.
Receive the same biomechanical analysis used by athletes at the highest levels, adapted to help you understand your health, your recovery, and your progress.